Angiotech Pharmaceuticals

Angiotech Pharmaceuticals Inc
Public
Industry Pharmaceutical
Headquarters Vancouver, British Columbia, Canada
Key people
 K. Thomas Bailey
Number of employees
 1450[1]
Website www.angiotech.com

Angiotech is a pharmaceutical company in Vancouver, British Columbia, Canada. Its products enhance the performance of medical devices and biomaterials through the use of pharmacotherapeutics. Angiotech is a global specialty pharmaceutical and medical device company that discovers, develops, and markets innovative technologies and medical products primarily for local diseases or for complications associated with medical device implants, surgical interventions and acute injury.

In April 2010, Angiotech acquired Haemacure manufacturing to develop human biological adhesives, hemostats and therapeutic proteins.

Angiotech, based in Vancouver, British Columbia, was founded in 1992 by William L. Hunter, M.D., Lindsay Machan, M.D., and Larry Arsenault, Ph.D.

References

  1. ↑ "Company Profile for Angiotech Pharmaceuticals Inc (CA;ANP)". Archived from the original on 2012-02-29. Retrieved 2008-10-10.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.